Finished product forms testing

Manufacturing validation data, which should aim to identify the critical process steps, especially for nonstandard manufacturing processes such as for new dosage forms, should be discussed in the development pharmaceutics section of the application. Validation data may be accepted based on closely related products. In-process control tests and acceptance limits should be included for any aspect where conformity with the finished product tests cannot otherwise be guaranteed (e.g., mixing, granulation, emulsification and nonpharmacopeial sterilization processes). 

CPMP/QWP/2570/98 Concept paper on the development of a CPMP note for guidance on in-use stability testing of non-sterile human medicinal products (November 1998) CPMP/QWP/2934/99 draft Note for guidance on in-use stability testing of human medicinal products (released for comment December 1999) CPMP/QWP/598/99 draft Note for guidance on process validation (released for comment September 1999, also issued under CVMP reference EMEA/CVMP/598/99 draft) CPMP/QWP/486/95 Note for guidance on manufacture of the finished dosage form (reissued April 1996)... 

The Committee for Proprietary Medicinal Products [8] applied the BCS, with certain requirements, to dispense with bioequivalency tests if the active pharmaceutical ingredient is class I and the in vitro dissolution of the finished dosage form is fast [9], An active substance is considered highly soluble if the amount contained in the HDS of an IR product is dissolved in 250 ml of each of three buffers within the range of pH 1-8 at 37°C (e.g., pH 1.0, 4.6, and 6.8). There should be linear and complete absorption, which indicates HP to reduce the possibility of an IR dosage form influencing the bioavailability [8], The similarity of the dissolution profiles of the test and reference products is demonstrated in each of three buffers within the range of pH 1-8 at 37°C (e.g., pH 1.0,4.6, and 6.8). If there is rapid dissolution of the product, where at least 85% of the active substance is dissolved within 15 min, no further comparison of the test and reference is required. Further requirements include that excipients be well established and have no interaction with the pharmacokinetics of the active substance and that the method of manufacture of finished product... 

The finished product is centrifuged and purified via a number of processes, including filtration, fractional distillation, condensation, crystallization, and chromatographic separation techniques. The purified API is tested and then it is ready to be formulated into the finished dosage form, as discussed in Section 10.6. Exhibit 10.5 illustrates some of the typical reagents for API manufacture and Exhibit 10.6 presents selected chemical reactions as examples of the... 

Stability tests on finished dosage forms and products Tests for conformance to pharmacopeial standards Exploratory studies on viruses and cell biology Tests of functionality and/or appropriateness of food additives... 

In the general chapter on microbial attributes of nonsterile pharmaceutical products, the guidance suggests that the presence of microbial contaminants in nonsterile products [25] can reduce or inactivate the therapeutic activity of the product and has the potential to adversely effect the health of the patients and recommends manufacturers to ensure that contamination levels are as low as possible for finished dosage forms. Microbial enumeration limits for raw materials (total aerobic microbial count and total combined yeasts and molds count) and finished dosage forms are described. For inhalation, nasal, and topical routes of administration, tests for total aerobic microbial count and total combined and yeast and mold count,... 

However, other analytical procedures, such as dissolution testing for dosage form or particle size determination for drug substance, are required for validation of analytical procedures. The revalidation of an analytical procedure is possible when, in particular circumstances, it could show changes in the synthesis of the drug substance, the composition of the finished product, or the analytical procedure. However, certain other changes may require validation as well. 

When the results of the yellow limestone clay and the red field clay analyses were processed by the potstat routine (10), an average of data from the two clays yielded a pattern that matched (except for sodium) the analytical pattern of pottery made of a mix of the two clays. In the first case, the two raw clays were simply ground and analyzed separately in the second case, the two clays were mixed in a water bath, sand and Dead Sea salt were added, a vessel was formed, dried, and fired, and this finished product was analyzed. The sand temper did not contribute significantly to the relative test element concentrations, but the salt addition did, of course, raise the sodium concentration. These results are graphed in Figure 2. 

Except for work on complete products, a test piece must be formed before the test can be carried out. In many cases, the test piece can be directly moulded but, particularly when tests on finished products are concerned, the specimens need to be cut and/or buffed to some particular geometric shape (Figure 4.1). It is convenient to consider separately, first the mixing and moulding leading up to a vulcanised (or thermoplastic) test piece or test sheet, and secondly the preparation of test pieces from moulded sheets or products. The preparation of test pieces for tests on raw rubber and unvulcanised compounds will be considered integrally with those tests in Chapter 6. 

Tests for mycotoxin contamination can be accomplished both on the finished product and on the raw form. The latter case prevents the manufacture of an unfit product, but it often implies trouble in the evaluation of the contamination in a batch. In this case, for a defined sample size, sample preparation, and analytical method, principles are available to evaluate the accuracy of the aflatoxin determination, depending on the availability of an accurate estimate of the variability associated with each step of the analytical sequence (11,12). A valuable effort to estimate the uncertainty of the analytical sequence as a whole was carried out by the FAO (13). 

Critical process steps are operations performed during dosage-form manufacture that can contribute to variability of the end product if not controlled. Since each type of dosage form requires different machinery and unit operations to produce the end product, the critical process steps will also differ. For each product considered suitable for retrospective validation, a list of these steps must be compiled following careful analysis of the process by technically competent persons. In a similar manner, in-process and finished-product tests should be screened to identify those that may be of some value. As a rule, tests in that the outcome is quantitative will be of greatest interest. 

Once this has been done, one can proceed to actual product testing utilizing these parameters and their specifications to validate that the process will produce acceptable product. The testing can be conducted on samples during the manufacture (in-process tests) or on the finished product (finished product tests). Each product may have its own idiosyncrasies requiring special tests, but generally the in-process and finished product tests that would be required for all solid dosage forms in process validation are as follows. 

Very strong bonding between polyurethane and metal is needed in items such as polyurethane mounts. When metal is used as reinforcement or for location and stabilization, a very good bond is needed to form the bridge between the rigid metal and the elastic properties of the polyurethane. Ideally, a test that could be performed on the finished product is desirable, but in practice this is often not the case. 

Stone," when it becomes a finished product, is an impalpable powder, of a deep saffron color, tinged with a redness deeper than that of the setting sun. It is the pure quintessence of Fire that has passed the fire a hundred times and stood every test. It is this that has the power to build a body impervious to fire, like itself. It builds up the lowest mineral form into a gold that endures the fire, and the lowest of organic forms into a form that resists successfully all the elements. Here, then, we have the basis, scientifically, for our belief in physical immortality, which with us is "believe-and-be-saved-by-Jesus" notion, as with the fanatical religionists, but rather a knowledge of the possibility of creating an indestructible body. 

First station usually has multiple preform injection molds where preforms are formed over core pins. The preforms have hemispherical closed ends (resembles a laboratory test tube). The other ends have an open bore, formed by the core pin. External details, such as the thread and neck flange for a screw-top container, are directly produced by injection molding. While the preform is still hot, the injection split mold is opened and the preforms, still on the core pins, are rotated to the blowing station two. Here the preforms are enclosed within the blow mold, and introducing blowing air through the core pins followed with cooling produces the BM. Blow molds opened and the finished products, still on the core pins, are rotated to an ejection station where they are stripped off mechanically and/or air. 

---